|
Match
|
Document |
Document Title |
|
|
7553500 |
Pharmaceutical composition having uniform drug distribution and potency
Pharmaceutical compositions having uniform drug distribution and potency utilizing laxofoxifene as an active ingredient and containing a silicon dioxide to reduce loss of the active ingredient...
|
|
|
7547474 |
Lubricious coatings for pharmaceutical applications
The invention provides pills and tablets having lubricious coating deposited over the outer surface of the pills and the tablets.
|
|
|
7537784 |
Modified release tablet of bupropion hydrochloride
A modified-release tablet of bupropion hydrochloride comprising (i) a core comprising an effective amount of bupropion hydrochloride, a binder, a lubricant; and (ii) a control releasing coat...
|
|
|
7510729 |
Combination of polyvinyl acetate with water-insoluble, acid-insoluble, or alkali-insoluble polymers used for the production of film coatings with highly controlled release and high stability
The invention relates to the combination of polyvinyl acetate and water-insoluble, acid-insoluble, or alkali-insoluble polymers used for producing film coatings for forms of administration in which...
|
|
|
7510728 |
Solid preparations
In a solid pharmaceutical preparation containing 1) a basic medicinal component having an unpleasant taste; 2) a saccharide; 3) a polyanionic polymer; 4) a corrigent; and 5) carboxymethylcellulose,...
|
|
|
7387791 |
Liposome drug delivery
This invention comprises pharmaceutical compositions for administering a biologically active compound to an animal. Particularly provided are proliposomal compositions that are advantageously used...
|
|
|
7303763 |
Compositions for conjugated estrogens and associated methods
Oral conjugated estrogen formulations are disclosed and described. In one aspect, the oral formulation may be a tablet having a core and one or more coatings thereon. In addition to conjugated...
|
|
|
7270831 |
Orally administrable opioid formulations having extended duration of effect
Sustained release oral solid dosage forms of opioid analgesics are provided as multiparticulate systems which are bioavailable and which provide effective blood levels of the opioid analgesic for...
|
|
|
7258872 |
Chromone enteric release formulation
Orally administered chromones have been found to be effective in the treatment of allergic conditions such as asthma, general food allergies, ulcerative colitis, atopic eczema, chronic urticaria,...
|
|
|
7235253 |
Powder containing physiologically active peptide
A method is disclosed for stabilizing a physiologically active peptide in a process of preparing a powder containing the physiologically active peptide by drying an aqueous liquid containing the...
|
|
|
7229643 |
Oral 2-methyl-thieno-benzodiazepine formulation
The invention provides a pharmaceutically elegant solid oral formulation of olanzapine and a process for making such formulation.
|
|
|
7229642 |
Amino acid modulated extended release dosage form
Disclosed herein is a oral extended release dosage form comprising a plurality of granules of an effective amount of a pharmaceutically active compound, at least one amino acid, and an...
|
|
|
7229640 |
Paroxetine controlled release compositions
A controlled release or delayed release formulation contains a selective serotonin reuptake inhibitor (SSRI) such as paroxtine.
|
|
|
7220430 |
Sustained-release preparation and process for producing the same
The present invention is to provide a sustained release preparation comprising a drug-containing core substance and a multilayered coating layer covering the core substance, wherein all adjacent...
|
|
|
7195769 |
Pharmaceutical compositions of anti-tubercular drugs and process for their preparation
A pharmaceutical composition of anti-tubercular drugs for oral use comprising Rifampicin and/or Isoniazid wherein the bioavailability of Rifampicin and/or other drugs is enhanced. Preferably the...
|
|
|
7169450 |
Enrobed core
An enrobed a core, such as a tablet core, that has a coating made of one or more patterned films each having portions that are visually distinct (e.g., differently colored) from one another and...
|
|
|
7147870 |
Osmotic device containing pseudoephedrine and an H1 antagonist
The present invention provides an osmotic device containing controlled release pseudoephedrine in the core in combination with a rapid release H1 antagonist in an external coat. A wide range of H1...
|
|
|
7125567 |
Process for producing an oral sustained-release preparation of fasudil hydrochloride
Disclosed is an oral sustained-release preparation which contains at least one active ingredient selected from the group consisting of fasudil hydrochloride and a hydrate thereof, the preparation...
|
|
|
7118762 |
Controlled release lipoic acid
A controlled release formulation of lipoic acid is disclosed. The lipoic acid is combined with excipient materials in such a way that those materials provide for gradual release of the lipoic acid...
|
|
|
7081255 |
Antifungal compositions with improved bioavailability
The present invention is concerned with novel pharmaceutical compositions of itraconazole which can be administered to a mammal suffering from a fungal infection, whereby a single such dosage form...
|
|
|
7037525 |
Oxacarbazepine film-coated tablets
The invention relates to formulations, e.g. film-coated tablets containing oxcarbazepine and to processes for the production of said formulations. The film-coated tablets have a tablet core...
|
|
|
RE39069 |
Multi-layered osmotic device
The present invention provides a simple and improved multi-layered osmotic device ( 1 ) that is capable of delivering a first active agent in an outer lamina ( 2 ) to one environment of use and a...
|
|
|
6994873 |
Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration
This invention refers to:
multiparticulate formulations of Lithium salts for oral administration constituted by either modified release granules or mixtures of modified and conventional...
|
|
|
6994872 |
Monolayer sugar-coated tablet and process for preparation thereof
This invention relates to a monolayer sugar-coated tablet which is coated with a sugar-coating liquid containing 30–54% by weight of saccharide, 2–10% by weight of polyethylene glycol and...
|
|
|
6974591 |
Method for producing a controlled-release preparation
The invention concerns a method for producing a controlled-release pharmaceutical preparation with a particle-containing coating, the coating being derived from an aqueous dispersion of a...
|
|
|
6960357 |
Chemical delivery device
The invention provides a controlled release dissolution and diffusion devices which can deliver an active ingredient at a constant or controlled-variable rate comprising an active ingredient and...
|
|
|
6958161 |
Modified release coated drug preparation
A modified release preparation having one or more coated core elements, each core element including an active ingredient and having a modified release coating, wherein a stabilising coat is...
|
|
|
6946146 |
Coating for a sustained release pharmaceutical composition
The present invention is directed to a coating composition for coating a solid dosage form of a medicament, where the coating composition controls the release of the medicament, said coating...
|
|
|
6899896 |
Hydrogel-driven layered drug dosage form
A controlled release dosage form for sertraline has a core comprising a sertraline-containing composition and a water-swellable composition wherein the water-swellable composition is in a separate...
|
|
|
6841515 |
Production and use of biosolid granules
This invention relates to the production and use of encapsulated and/or concentrically-constructed fertilizer or bioremediation granules such as, for example, granules of 0.5 mm to 10 mm in...
|
|
|
6833340 |
System for delivery of active substances
A method of delivery of active substances to a water-filled environment, specifically a toilet bowl, with a water-soluble polymer as the primary delivery means. The present invention is activated...
|
|
|
6827947 |
Film coating
A film coating composition suitable for use in coating pharmaceutical formulations to provide modified release comprising a dispersion which includes: a) an acrylic polymer, b) a vinyl acetate...
|
|
|
6808721 |
Methods for coating pharmaceutical core tablets
A formulation comprising, and process for preparing, improved oral dosage forms of 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin
-4-yl-ethoxy)-naphthalen-1-yl]-urea, a chemical...
|
|
|
6770297 |
Controlled release delivery system of solid dosage form
This invention relates to a controlled release delivery system of solid dosage form with a plurality of controls on the release of the active ingredient or ingredients.
|
|
|
6753012 |
Method for coating pharmaceutical dosage forms
The invention provides a process for coating a branded pharmaceutical dosage form for the purpose of covering any embossed or printed matter or any colored coating by the application of an amount...
|
|
|
6750249 |
Controlled release oral preparations of esculetin and its derivatives
The present invention relates to an oral preparation of esculetin with controlled release. The oral preparation of esculetin with controlled release of the present invention comprises a gel-forming...
|
|
|
6749867 |
Delivery system for omeprazole and its salts
The present invention provides a time-release dosage form for delivering an acid-labile pharmaceutical, such as omeprazole, into the upper portion of the gastrointestinal tract downstream of the...
|
|
|
6749864 |
Stabilized pharmaceutical composition
The pharmaceutical composition of the invention, which comprises a benzimidazole compound of the formula wherein R 1 is hydrogen, alkyl, halogen, cyano, carboxy, carboalkoxy, carboalkoxyalkyl,...
|
|
|
6743445 |
Low temperature coatings
A method of coating an active material is provided. The method comprises contacting an active material with a film-forming composition comprising an aqueous dispersion of an amylose-alcohol...
|
|
|
6733784 |
Coated, platform-generating tablet
An expanding tablet is described comprising a drug release controlling membrane material. After swallowing, the tablet hydrates and expands such that the membrane ruptures to directly expose some...
|
|
|
6730321 |
Press coated, pulsatile drug delivery system suitable for oral administration
A press-coated tablet suitable for oral administration, comprising an immediate-release compartment comprising a compressed blend of an active agent. The immediate-release compartment has a...
|
|
|
6726931 |
Process for preparing oral sustained-release formulation of felodipine
The present invention relates to a process for producing an oral sustained-release pharmaceutical composition of felodipine. The process includes mixing together felodipine with at least an ionic...
|
|
|
6726930 |
Sustained release heterodisperse hydrogel systems for insoluble drugs
A sustained release pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, an optional cationic cross-linking agent, and a...
|
|
|
6723737 |
Methods, pharmaceutical and therapeutic compostions for administering adenosine
The invention discloses methods for the chronic administration of adenosine, which contrary to the acute delivery of the drug by injection or infusion, acts in desensitizing adenosine receptors...
|
|
|
6723342 |
Edible coating composition
An edible, hardenable coating composition containing microcrystalline cellulose and carrageenan and at least one of a strengthening polymer, a plasticizer, a surface active agent or a combination...
|
|
|
6709678 |
Easy to swallow oral medicament composition
An oral composition which is adapted to be dispersed in an aqueous carrier substantially immediately prior to administration comprises a multiplicity of particles comprising an active substance,...
|
|
|
6706284 |
Bitterness-reduced oral pharmaceutical composition
The invention relates to an oral pharmaceutical composition which has excellent drug release-controlling ability in the mouth even 5 to 10 minutes after its administration and also has excellent...
|
|
|
6699508 |
Sustained release oral preparations of fasudil hydrochloride
An oral sustained-release preparation which contains at least one active ingredient selected from the group consisting of fasudil hydrochloride and a hydrate thereof is disclosed. A method for...
|
|
|
6696085 |
Use of an acrylic type polymer as disintegrating agent
The present invention provides for the use of a polymer of the acrylic type as a disintegration agent.
|
|
|
6676966 |
Extended release metformin hydrochloride formulations
An extended release formulation of metformin hydrochloride is disclosed. The metformin hydrochloride is encased within polymeric film layers providing for gradual release of the metformin...
|